Pancreatic Cancer Research

ResearcherSoutheast Louisiana Veterans Health CareActive in the last 2 years

Sharmila Shankar

Matched on ORCID iD 0000-0002-2854-3678; OpenAlex author ID A5000344564; NIH RePORTER profile ID 8608150. Sources: OpenAlex.

Their work

Papers
24 (first author 0, last author 12)
Trials
0
Grants
2
Labs led
2
Collaborators
18
Papers, trials and grants by year

2011: 3 papers · 2012: 4 papers · 2013: 3 papers · 2014: 2 papers · 2015: 3 papers · 2016: 1 paper, 1 grant · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 grant · 2026: 1 paper

Papers 24

  1. EN2 Regulates Pancreatic Cancer Initiation, Progression, and Epithelial-Mesenchymal Transition Through the Notch Signalling Pathway. Last author DOI 10.1111/jcmm.71158↗
  2. Riluzole regulates pancreatic cancer cell metabolism by suppressing the Wnt-β-catenin pathway. Co-author DOI 10.1038/s41598-022-13472-y↗
  3. Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1-Cre and LSL-Kr… Co-author DOI 10.1111/jcmm.17092↗
  4. Corrigendum to 'GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft' [Canc. Lett. 330 (2013) 22-32]. Last author DOI 10.1016/j.canlet.2021.07.028↗
  5. The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives. Co-author DOI 10.1111/jcmm.15413↗
  6. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog. Last author DOI 10.1111/jcmm.14178↗
  7. Triacetyl resveratrol upregulates miRNA‑200 and suppresses the Shh pathway in pancreatic cancer: A potential therapeutic agent. Last author DOI 10.3892/ijo.2019.4700↗
  8. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway. Last author DOI 10.1093/carcin/bgx070↗
  9. Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker. Co-author DOI 10.18632/oncotarget.10860↗
  10. Recent advances in pancreatic cancer: biology, treatment, and prevention. Last author DOI 10.1016/j.bbcan.2015.04.003↗
  11. Anthothecol-encapsulated PLGA nanoparticles inhibit pancreatic cancer stem cell growth by modulating sonic hedgehog pathway. Co-author DOI 10.1016/j.nano.2015.07.001↗
  12. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth. Co-author DOI 10.18632/oncotarget.5055↗
  13. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice. Last author DOI 10.1016/j.canlet.2014.06.021↗
  14. Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog p… Co-author DOI 10.1371/journal.pone.0092161↗
  15. Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway. Last author DOI 10.1007/s11010-012-1493-6↗
  16. GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft. Last author DOI 10.1016/j.canlet.2012.11.018↗
  17. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice. Co-author DOI 10.1016/j.canlet.2013.05.009↗
  18. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Co-author DOI 10.1002/ijc.26323↗
  19. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Co-author DOI 10.1016/j.bcp.2012.08.007↗
  20. EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer. Co-author DOI 10.1371/journal.pone.0031067↗
  21. Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal. Last author DOI 10.1371/journal.pone.0046083↗
  22. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epith… Co-author DOI 10.1371/journal.pone.0016530↗
  23. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. Last author DOI 10.1371/journal.pone.0024099↗
  24. Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms. Last author DOI 10.1371/journal.pone.0027306↗

Grants 2

  1. Role of Alcohol as a risk factor in the induction of Pancreatic Carcinogenesis I01BX004513↗
  2. Inhibition of Cancer stem cell characterisitcs in Pancreatic Cancer I01BX001583↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rakesh K. Srivastava · 24 shared papers, 2011–2026 · strength 2.07
  2. Yiming Ma · 6 shared papers, 2016–2026 · strength 0.96
  3. Sanjit Kumer Roy · 4 shared papers, 2013–2022 · strength 0.55
  4. Wei Yu · 5 shared papers, 2015–2022 · strength 0.54
  5. Junsheng Fu · 7 shared papers, 2011–2021 · strength 0.47
  6. Bao Lam · 2 shared papers, 2020–2022 · strength 0.32
  7. Wei Yu · 1 shared paper, 2026 · strength 0.32
  8. Su‐Ni Tang · 7 shared papers, 2011–2014 · strength 0.29
  9. Mariana Rodova · 4 shared papers, 2012–2021 · strength 0.26
  10. Minzhao Huang · 2 shared papers, 2014 · strength 0.09
  11. Brahma Nand Singh · 2 shared papers, 2011–2012 · strength 0.08
  12. Farzad Alemi · 1 shared paper, 2017 · strength 0.08
  13. Divya Kumari Singh · 1 shared paper, 2015 · strength 0.07
  14. Raj Kumar Verma · 1 shared paper, 2015 · strength 0.06
  15. Narinder Sharma · 1 shared paper, 2015 · strength 0.06
  16. Shih-Hui Li · 1 shared paper, 2013 · strength 0.05
  17. Min Zhao · 1 shared paper, 2013 · strength 0.05
  18. Dara Nalls · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.